Annals of Neurology · 2005 · 64 citations · 8 references
Life SciencesNeurologyNeuroscienceClinical NeuroscienceNeurodegenerationNeuropsychiatryDopaminergic SignalingHuntington DiseaseNeurodegenerative Disease ImagingNeurodegenerative DiseasesNeurodegenerative DisordersDisorderDopamine Receptor ImagingDopamine Receptor SubtypesGraft Viability MonitoringHuntington Disease ImagingPostoperative Graft Viability AssessmentStriatal Dopamine FunctionTransplantation
Huntington's disease (HD) is a progressive disorder with no known cure. We report two-year postoperative positron emission tomography (PET) data from 7 HD patients who underwent intrastriatal fetal transplantation. Patients showed widespread reductions in glucose uptake with no significant change over 2 years. Dopamine receptor binding was significantly reduced in HD striatum. D1 binding did not change significantly following transplantation, but there was a significant loss of D2 binding. These findings may reflect loss of graft viability and/or disease progression. There was no significant relationship between changes in PET and clinical function. In summary, there was no benefit from transplantation.
8
Bilateral human fetal striatal transplantation in Huntington’s disease
Roberta A. Hauser, Sarah Furtado, Cynthia R. Cimino et al. · Neurology · 2002 · 245 citations